E-PaperIntas Pharmaceuticals News
Pharma firms to tap M&A opportunities to gain scale, tide over challenges
Indian drug makers are expected to evaluate opportunities arising out of portfolio rationalization exercise of multinational pharma companies such Teva, Novartis, Sanofi and Mallinckrodt
3 min read26 Jan 20183 firms may face action for selling hypertension drug without approval
Central Drug Standards Control Organisation has initiated an inquiry against Zydus Cadila, Eris Lifesciences and Intas Pharmaceuticals for selling hypertension drug without approval
2 min read5 Jan 2018Biocon launches biosimilar bevacizumab for cancer treatment in India
Biocon's biosimilar bevacizumab is indicated as a first-line treatment of patients with metastatic colorectal cancer and also used to treat lung, kidney, cervical, ovarian and brain cancers
1 min read23 Nov 2017Aurobindo Pharma, Intas in race for Teva’s European assets
Aurobindo Pharma and Intas are vying for Teva Pharma's European assets that include oncology, pain management and women's health divisions of the firm
2 min read16 Aug 2017US FDA finds quality lapses at Intas Pharma’s Moraiya biotech unit
The FDA has issued a Form 483 with 14 observations relating to deviations from good manufacturing practices to Intas Pharmaceuticals' biotech facility in Moraiya, Gujarat
1 min read21 Jul 2017Private equity, venture capital exits worth $1 billion recorded in April: EY
Private equity and venture capital exits in 2017 now total $3 billion, which is 46% of the aggregate value recorded in 2016
3 min read12 May 2017Capital International buys 3% stake in Intas Pharmaceuticals for $107 million
PE firm buys stake from ChrysCapital in a transaction that values Intas Pharmaceuticals at about $3.5 billion
2 min read3 Apr 2017India risks missing boat as biosimilars shake up drug industry
Just three Indian groupsBiocon, Dr Reddy's and Intas Pharmaare working with partners on so-called biosimilars aimed at the US and Europe
3 min read15 Oct 2015Temasek buys 10.16% stake in Intas Pharmaceuticals
Temasek buys stake through secondary purchase of shares from private equity firm ChrysCapital
2 min read11 Nov 2014Intas Pharma may offload 10% to raise Rs200 cr from market
Intas Pharma may offload 10% to raise Rs200 cr from market
2 min read29 Sep 2007Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared